Overview

A Study of Gaboxadol in Primary Insomnia

Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
0
Participant gender:
All
Summary
To evaluate the safety and tolerability of gaboxadol in primary insomnia.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
H. Lundbeck A/S
Treatments:
Gaboxadol
Criteria
Inclusion Criteria:

- patients with Primary insomnia